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Abstract
Background: Brain homeostasis deteriorates in sepsis, giving rise to a mostly reversible sepsis-associated
encephalopathy (SAE). Some survivors experience chronic cognitive dysfunction thought to be caused by
permanent brain injury. In this study, we investigated neuroaxonal pathology in sepsis.
Methods: We conducted a longitudinal, prospective translational study involving (1) experimental sepsis in an
animal model; (2) postmortem studies of brain from patients with sepsis; and (3) a prospective, longitudinal human
sepsis cohort study at university laboratory and intensive care units (ICUs). Thirteen ICU patients with septic shock,
five ICU patients who died as a result of sepsis, fourteen fluid-resuscitated Wistar rats with fecal peritonitis, eleven
sham-operated rats, and three human and four rat control subjects were included. Immunohistologic and protein
biomarker analysis were performed on rat brain tissue at baseline and 24, 48, and 72 h after sepsis induction and in
sham-treated rats. Immunohistochemistry was performed on human brain tissue from sepsis nonsurvivors and in
control patients without sepsis. The clinical diagnostics of SAE comprised longitudinal clinical data collection and
magnetic resonance imaging (MRI) and electroencephalographic assessments. Statistical analyses were performed
using SAS software (version 9.4; SAS Institute, Inc., Cary, NC, USA). Because of non-Gaussian distribution, the
nonparametric Wilcoxon test general linear models and the Spearman correlation coefficient were used.
Results: In postmortem rat and human brain samples, neurofilament phosphoform, β-amyloid precursor protein,
β-tubulin, and H&E stains distinguished scattered ischemic lesions from diffuse neuroaxonal injury in septic animals,
which were absent in controls. These two patterns of neuroaxonal damage were consistently found in septic but
not control human postmortem brains. In experimental sepsis, the time from sepsis onset correlated with tissue
neurofilament levels (R = 0.53, p = 0.045) but not glial fibrillary acidic protein. Of 13 patients with sepsis who had
clinical features of SAE, MRI detected diffuse axonal injury in 9 and ischemia in 3 patients.
Conclusions: Ischemic and diffuse neuroaxonal injury to the brain in experimental sepsis, human postmortem
brains, and in vivo MRI suggest these two distinct lesion types to be relevant. Future studies should be focused on
body fluid biomarkers to detect and monitor brain injury in sepsis. The relationship of neurofilament levels with
time from sepsis onset may be of prognostic value.
Trial registration: ClinicalTrials.gov, NCT02442986. Registered on May 13, 2015.
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Background
Sepsis still carries a high incidence and mortality rate [1,
2]. Furthermore, sepsis-associated encephalopathy (SAE)
in survivors can result in long-term physical, cognitive,
and psychological impairment with high socioeconomic
relevance [2, 3]. The condition is thought to be underre-
cognized [4, 5]. Current understanding of pathophysio-
logical mechanisms of SAE is limited; more insights into
this important field are needed [6, 7]. Animal models
can shed some light on the complex pathophysiological
mechanisms of SAE [8–10]. Microglial activation, mito-
chondrial dysfunction, oxidative stress, neuroinflamma-
tion, and neuronal apoptosis are potential risk factors
for SAE, resulting in axonal degeneration [11–13]. The
accumulation of β-amyloid peptide (Aβ), a part of the β-
amyloid precursor protein (βAPP), forms neurotoxic
amyloid plaques in the septic brain [14, 15]. The detec-
tion of misfolded proteins in the septic brain was linked
to long-term cognitive deficits in rats [14]. Histologic
demonstration of axonal injury by βAPP staining is now
widely used in animal models and human neuropathol-
ogy [16–18]. Beside advances in histology, in vivo diag-
nostics can detect axonal injury in SAE [19, 20]. Imaging
and biomarker studies have been used to detect brain in-
jury and predict neurologic outcome [21–23]. Neverthe-
less, both the primary mechanisms underlying SAE and
the temporal development of SAE over the course of
sepsis remain elusive [24]. We thus conducted a transla-
tional study to compare neuropathologic findings de-
rived from postmortem brain samples of septic rats and
humans with in vivo clinical and imaging results from
patients with sepsis who had SAE. A correlation between
newly formed septic brain lesions detected by neuroim-
aging with neuropathologic findings may provide better
understanding of the temporal relationship between sep-
sis and the onset of SAE.
Methods
Rat model of sepsis-associated encephalopathy
All experiments were performed according to local eth-
ics committee (University College London) and Home
Office (UK) guidelines under the 1986 Scientific Proce-
dures Act. Adult male Wistar rats (approximate body
weight 300 g, 12–14 weeks old) were used to generate a
3-day in vivo sepsis model of fecal peritonitis. Sepsis in-
duction and experimental procedures were performed as
described in detail before [25]. Four naive (noninstru-
mented) rats, eleven sham-operated, and fourteen septic
rats were included. All rats were instrumented under
brief anesthesia with tunneled carotid arterial (left side)
and jugular venous (right side) catheters to monitor
hemodynamics, sample blood, and infuse fluids. The
catheters were mounted onto a swivel-tether system,
allowing the rat, on recovery from anesthesia, to have
free movement in its cage and ad libitum access food
and water. Sepsis was induced 24 h later by an intraperi-
toneal injection of fecal slurry (0.63 mg/100 g body
weight, prepared from bowel contents of rats from the
same batch). From 2 h postinsult, fluid resuscitation
using a 1:1 solution of colloid and 5% glucose was ad-
ministered at a rate of 10 ml/h for the first 24 h and
then halved on successive days to ensure normovolemia
and normoglycemia. All septic animals showed clinical
signs of sepsis by decreased movements, decreased alert-
ness, hunched posture, and piloerection from about 12 h
postinjection of fecal slurry. Rats were killed by cervical
dislocation under deep isoflurane anesthesia either 24,
48, or 72 h after sepsis induction. After craniectomy,
brains were removed within a few minutes of death. The
brain was dissected through the midline into halves.
One half was snap-frozen in liquid nitrogen; the other
half was placed in formalin.
Histology, immunohistochemistry, and protein extraction
from septic rat and human brain
Neuropathologists (MG, FS) were masked to the condi-
tion of rat and human brain samples. Human and rat
brain tissue from frontal lobe areas and the cerebellum
were processed in paraffin wax using a standard 7-day
dehydration and paraffin-embedding protocol on an au-
tomated tissue processor. Five-micrometer paraffin sec-
tions were cut, mounted onto SuperfrostTM glass slides
and dried overnight at 37 °C. For the general histologic
examination, sections were dewaxed, rehydrated, and
stained with H&E using a standard protocol. For the im-
munohistochemical detection of neurofilaments (Nf)
and glial fibrillary acidic protein (GFAP), the sections
were dewaxed and rehydrated before being placed in
600 ml of 0.1 M citrate buffer (pH 6.0) and microwaved
at full power for 15 minutes in a 850-W microwave
oven. The four sections were allowed to cool before be-
ing rinsed in 0.05 M PBS, pH 7.4, and incubated over-
night at room temperature in either a mouse
monoclonal antibody directed against an epitope com-
mon to the 70 and 200 kDa Nf proteins (clone 2 F11 di-
luted 1:20; MP Biomedicals Inc., Santa Ana, CA, USA),
β-tubulin (1:200; Sigma-Aldrich, Gillingham, UK), β-
APP (1:500; Dako, Ely, UK), or a rabbit polyclonal anti-
body directed against GFAP (diluted 1:1500; Dako).
After being washed in PBS, the sections were incubated
in a biotinylated secondary antibody for 1 h (Dako),
followed by a washing step and incubation in
peroxidase-conjugated streptavidin for 1 h (diluted
1:300; Sigma-Aldrich) All dilutions were in PBS with
0.1% Triton-X. Antibody localization was visualized by
incubating the sections for 10 minutes at room
temperature in 0.05% diaminobenzidine with 0.04%
NiCl2 and 0.01% hydrogen peroxide added. The sections
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were then counterstained with hematoxylin, dehydrated,
cleared, and mounted.
The dry weight of the snap-frozen rat brain tissue was
0.56 to 1.94 g. Barbitone ethylenediaminetetraacetic acid
(EDTA) buffer (pH 9.6) containing a protease inhibitor
cocktail (P8340; Sigma-Aldrich) was added to 1:2 wt/vol.
The samples were homogenized on ice using an
ULTRA-TURRAX T 25 instrument (IKA-Werke GmbH
& Co., Staufen, Germany) for 1 minute, followed by son-
ication on ice for 1 minute. Samples were refrozen at
−70 °C and then thawed at 30 °C, and 2 ml of sample
was added to 5 ml of diisopropyl ether and 2 ml of bar-
bitone EDTA buffer. After a mixing step, the samples
were spun at 25,000 × g and 4 °C for 30 minutes, and the
protein soluble fraction was collected. Tissue levels of
Nf heavy chain (NfHSMI35) and GFAP were measured by
enzyme-linked immunosorbent assay (ELISA), and total
protein was measured using the Lowry method [26, 27].
In vivo neurologic assessment of patients with sepsis
The study was approved by the local ethics board at
Rostock University (A 2012-0058) and registered as a
clinical trial (ClinicalTrials.gov, NCT02442986). The pa-
tient recruitment period was from November 2012 to
May 2015. All patients or their legal representatives
signed written informed consent forms before study in-
clusion. Inclusion criteria for participants were aged ≥
18 years and the presence of severe sepsis or septic
shock according to the criteria used at the time [28]. Ex-
clusion criteria were preexisting cerebrovascular dis-
eases, including dementia, preexisting neuromuscular
disease, high-dose glucocorticoid administration
(>300 mg hydrocortisone or equivalent per day), preex-
isting renal replacement therapy, coagulopathy with ac-
tive bleeding, and frequent administration of
neuromuscular blocking agents (more than three times
per week). Twenty patients with septic shock were in-
cluded prospectively in the study. Seven participants
without magnetic resonance imaging (MRI) examina-
tions were excluded for the following reasons: death be-
fore MRI performed (n = 1), only cranial computed
tomographic scan available owing to contraindication for
MRI (n = 2), disclaimer for MRI from patient/legal repre-
sentative after study inclusion (n = 2), and repeated sur-
gery/unstable patient (n = 2). In total, 13 patients were
enrolled prospectively in this single-center, longitudinal,
observational study.
Clinical assessment protocol
All patients were clinically assessed by an interdisciplin-
ary team consisting of intensivists and neurologists expe-
rienced in critical and neurocritical care using a
validated scales for severity of disease: Acute Physiology
and Chronic Health Evaluation II at ICU admission and
the Sepsis-related Organ Failure Assessment score [29,
30]. All patients received standardized management ac-
cording to guideline recommendations [2, 28]. After
study inclusion, patients were longitudinally evaluated
(study days 1, 3, 7, and 28) for their level of conscious-
ness and for signs of SAE, such as confusion, agitation,
hallucinations, or acute changes in mental status using
the Glasgow Coma Scale, the Richmond Agitation-
Sedation Scale, and the Confusion Assessment Method
in the Intensive Care Unit (CAM-ICU) [31–34]. A med-
ical history was taken from all patients, if obtainable, or
from their next of kin. A standardized neurologic exam-
ination was performed on all patients by an experienced
neurologist (MW). This comprised a detailed status of
the level of consciousness; brainstem reflexes and func-
tion; deep tendon reflexes; and sensory and motor func-
tion, including muscular strength testing using the
Medical Research Council dyspnea scale score [35, 36].
Electroencephalography
In addition to clinical assessment, all patients underwent
electroencephalography (EEG) within the first 72 h after
sepsis was diagnosed. The international 10–20 system
was used for standard electrode placements with imped-
ance level < 5 kΩ on a mobile EEG unit (ED 14; Madaus
Schwarzer, Munich, Germany). All EEG recordings were
done over 30 minutes. Patients were stimulated by ver-
bal command. If no response to verbal stimulation could
be obtained, sternal rub or nail bed compression were
performed. The EEG recordings were assessed by an ex-
perienced accredited reader (MW) according to the
method described by Young et al. [37]. Patients with
analgosedation (standard regimen with continuous infu-
sion of propofol and sufentanil) had a sedation holiday
of 30 minutes before EEG recording.
Magnetic resonance imaging
A 1.5-T magnet system (MAGNETOM Avanto; Siemens
Healthcare, Erlangen, Germany) was used in seven pa-
tients, and a 3.0-T magnet system (MAGNETOM Verio;
Siemens Healthcare) was used in six patients. A stan-
dardized MRI protocol was used, and all MRI findings
were analyzed by an experienced neuroradiologist (AG).
MRI examinations included coronal T1-weighted images
(with and without contrast medium), sagittal and axial
T2-weighted sequences, axial fluid-attenuated inversion
recovery (FLAIR), and axial T2*-weighted gradient
recalled echo sequences. Additionally, axial echo planar
imaging diffusion-weighted imaging (DWI) sequences,
apparent diffusion coefficient maps, and time-of-flight
magnetic resonance angiography were performed. The
extent of white matter hyperintensities (WMH) as an
imaging marker of brain injury was graded on a previ-
ously validated scale. WMH were scored according to
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their number and size from grade 0 (no lesions) through
grade 1 (punctiform), grade 2 (patchy or confluent), and
grade 3 (diffuse) [21, 38]. An MRI examination was per-
formed as soon as the patient was clinically stable for in-
house transfer using continuous patient monitoring (Ex-
pression MR400 monitor; Phillips Healthcare Deutsch-
land GmbH, Hamburg, Germany).
Statistical analysis
All statistical analyses were performed using SAS soft-
ware (version 9.4; SAS Institute, Inc., Cary, NC, USA).
Because of non-Gaussian distribution, the nonparamet-
ric Wilcoxon test was used for comparing two independ-
ent variables. Two-way unbalanced analysis of variance
(general linear model) was used for comparing more
than two independent variables, followed post hoc ana-
lysis if significance was achieved. The F values providing
the degrees of freedom and the number of samples in-
cluded in each particular analysis are shown. The linear
correlation between continuous variables was evaluated
using the Spearman correlation coefficient. Linear re-
gression analysis was performed using the least squares
method. A p value < 0.05 was considered significant.
Results
Experimental sepsis in rats
Average total protein levels were comparable between
groups (naive 7.4 ± 2.6 g/L, sham 8.7 ± 3.9 g/L, and sep-
sis 8.9 ± 2.9 g/L). We found that brain tissue levels for
GFAP were not statistically different when we compared
sham-treated (0.27 ± 0.19 ng/g total protein) and septic
(0.29 ± 0.21 ng/g total protein) rats with naive rats (0.34
± 0.11 ng/g total protein). Average brain tissue levels of
NfHSMI35 were higher in sham-treated (2.6 ± 2.2 ng/g
total protein) and septic (1.8 ± 1.7 ng/g total protein) rats
than in naive rats (0.8 ± 0.6 ng/g total protein), but this
difference failed to reach statistical difference (p = 0.094
and p = 0.356, respectively) (Table 1). In septic rat brain
tissue, there was a mild correlation between NfHSMI35
levels and time from sepsis induction (R = 0.53, p =
0.045) that was not seen for either GFAP (R = −0.39, p =
0.154) or total protein (R = −0.05, p = 0.854). No such
correlations were observed in either sham-treated or
naive rat brain samples. The immunohistochemistry of
brain tissue from septic compared with naive and sham-
treated rats showed two types of lesions. The normal
white matter appearance in a sham-treated rat brain is
shown in Fig. 1a. Typically, βAPP staining is restricted
to the neuronal cell soma and the proximal axonal hil-
lock. For comparison, in septic brain tissue, diffuse,
more widespread axonal staining is seen (Fig. 1b). This
pathologic staining was most marked for long white
matter tracts (Fig. 1c). Spinal tissue was not available.
The second lesion type seen comprised scattered small
ischemic lesions (Fig. 1d). The early inflammatory com-
ponent suggests a septic embolic etiology. These pockets
of ischemic, inflammatory lesions stained intensely for
βAPP, extending peripherally from the core lesion
(Fig. 1e). An alternative marker for early axonal injury is
β-tubulin. In sham-treated rats, the axonal staining for
β-tubulin is neat and continuous, as expected on the
basis of preserved neuronal (Fig. 1f ) and axonal (Fig. 1g)
integrity. This is best appreciated in the magnified insets
in Fig. 1g and h. In contrast to the diffuse axonal path-
ology present in septic rat brains, axonal β-tubulin is
subjected to proteolysis and broken up, giving the im-
pression of a structurally disorganized axonal (Fig. 1h)
and neuronal cytoskeleton (Fig. 1i).
Human postmortem sepsis brain study
Postmortem brain tissue was available from five patients
who died as a result of sepsis (mean age 64 years, one
male patient). The three control subjects (mean age
37 years, all male) died as a result of other causes: sui-
cide, assault, and road traffic accident (RTA) without
concurrent brain injury.
Causes leading to death in sepsis were directly related
to multiorgan failure, but one patient had additional
complications in the form of a gastrointestinal and intra-
cranial hemorrhage. Careful examination of this patient’s
brain did not reveal any evidence of an amyloid angiopa-
thy. The immunohistochemical results of brain tissue
from the patients with sepsis are summarized in Fig. 2.
Patient 1, a 56-year-old male control subject, died after
having an RTA. There was diffuse staining of axons for
βAPP restricted to the axonal hillock (Fig. 2a, arrows).
More extensive axonal βAPP staining was seen in patient
2, a 55-year-old male patient with sepsis (Fig. 2b). There
was beadlike swelling indicating axonal pathology. In
addition, staining for nonphosphorylated NfH (SMI32)
Table 1 Brain tissue levels of total protein, glial fibrillary acidic protein, and neurofilament heavy chain in naive, sham-treated, and
septic rats
Parameter Naive group (n = 4) Sham group (n = 11) Septic group (n = 14) p Value
Total protein levels, g/L 7.4 ± 2.6 8.7 ± 3.9 8.9 ± 2.9 >0.05
Brain tissue GFAP levels, ng/g total protein 0.34 ± 0.11 0.27 ± 0.19 0.29 ± 0.21 >0.05
Brain tissue NfHSMI35 levels, ng/g total protein 0.8 ± 0.6 2.6 ± 2.2 1.8 ± 1.7 >0.05
Abbreviations: GFAP Glial fibrillary acidic protein, NfH Neurofilament heavy chain, Naive group Controls (noninstrumented rats), Sham group Instrumented rats
without injection of fecal slurry, Septic group Instrumented rats with injection of fecal slurry
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demonstrated the presence of a large amount of axonal
endbulbs, a sign of axonal degeneration (Fig. 2c). Next,
scattered ischemic lesions were visible in patient 3, a 67-
year-old female who died as a result of multiorgan fail-
ure due to sepsis (Fig. 2d). Amyloid plaques were found
only in a 79-year-old female (Fig. 2e). Her medical his-
tory was not suggestive of cognitive impairment such as
that seen with a neurodegenerative dementia; however, a
formal neuropsychological assessment done before oc-
currence of sepsis was not available. Of note, the degree
of diffuse deep white matter axonal injury was the most
severe of all patients with sepsis (Fig. 2f ).
Clinical presentation of human septic brain injury in vivo
Clinical presentation of SAE and mortality in patients with
sepsis
The baseline characteristics of the septic cohort are
summarized in Table 2. In 10 of the 13 patients, clinical
signs of SAE were present at the onset of sepsis. Three
patients developed septic shock perioperatively, requir-
ing continued ventilation and sedation and thus preclud-
ing reliable cognitive assessments. Longitudinal CAM-
ICU scoring was positive in 8 of the 13 patients. Three
patients died within the 100-day follow-up period.
EEG findings in patients with sepsis
An EEG recording was done within a median of 2 days
(range 0–4) after the onset of sepsis. At the time of re-
cording, 7 of the 13 patients did not require sedation,
and the remaining 6 had their sedation interrupted
30 minutes prior to undergoing EEG. EEG revealed en-
cephalopathy of different extents in all patients (Table 3)
Additional file 1.
MRI findings in patients with sepsis
Patients underwent MRI examination as soon as their
clinical situation was deemed stable for in-house transfer.
The median time from the onset of sepsis to brain MRI
was 9 days (range 4–27). Reasons for delayed time to MRI
were repeated surgical interventions in patients 1 and 11
and organizational reasons in patient 7. The MRI showed
brain injury in 9 of 13 patients (Table 3, Fig. 3). The first
pattern of WMH was punctiform (n = 3), patchy/confluent
Fig. 1 Brain lesions seen in rat sepsis model. a Central brain white matter immunohistochemistry in sham-treated animals (controls) shows characteristic
neuronal soma with restricted staining for β-amyloid precursor protein (βAPP) (arrows). b In septic animals, brain tissue from the same locations showed
abnormal and more widespread axonal staining extending from the axonal hillock to the proximal axon (arrows). c Abnormal axonal βAPP staining follows
white matter tracts (arrows). d There are also pockets of inflammatory and ischemic brain lesions seen in the rat sepsis model (H&E stain; arrow). e Staining
of such lesions shows intense neuronal and axonal staining for βAPP (arrows). f Staining of lesions of sham-treated animals for β-tubulin in the
magnification field is crisp and shows integrity of the neuroaxonal compartment (overview, inset; original magnification × 10). g Likewise, the integrity of
white matter tracts in sham-treated animals can be seen (×10; inset, original magnification × 40). h There is severe structural disorganization of the β-
tubulin network in white matter tracts of the septic animals. i The level of structural β-tubulin disorganization in the septic rat brain is best observed at
greater magnification (original magnification × 40) of the neuroaxonal compartment from the same location as that taken from the sham model
shown in (f)
Ehler et al. Critical Care  (2017) 21:262 Page 5 of 10
Fig. 2 Brain lesions seen in postmortem human tissue. a Patient 1 (control): Diffuse staining of axons (arrows), extending from the axonal hillock (β-
amyloid precursor protein [βAPP]). b Extensive diffuse axonal injury is shown in patient 2 (sepsis). Staining for βAPP is not restricted to the axonal hillock
but is seen throughout the white matter tracts. Multiple axonal endbulbs can also be seen (small arrowheads). c Disruption of the deep white matter axons
and the presence of axonal end bulbs are widespread based on dephosphorylated neurofilament heavy chain (SMI32). d Patient 3: Small areas of ischemic
lesions can be seen throughout the brain (βAPP). e Patient 4: One type of lesion not observed in the animal model is shown. Amyloid plaques (arrow) are
present and scattered throughout the brain tissue (βAPP). f In this patient, diffuse deep white matter axonal damage (arrows) is the most severe of this
series (βAPP)



















1/F 63 20/18 72 Yes Yes 72 (dead) 72 (dead) No
2/F 82 29/15 12 Yes Yes 22 30 Yes
3/M 73 42/15 20 n.a. No 20 20 Yes
4/M 57 27/11 2 Yes Yes 9 29 Yes
5/M 55 12/6 0 Yes No 3 30 Yes
6/F 80 24/12 2 Yes Yes 20 (dead) 20 (dead) No
7/M 44 40/8 10 Yes Yes 20 33 Yes
8/F 76 39/12 16 n.a. Yes 16 (dead) 16 (dead) No
9/F 74 23/13 9 Yes No 21 31 Yes
10/M 75 37/10 2 Yes Yes 4 26 Yes
11/F 54 48/11 8 n.a. No 23 45 Yes
12/F 60 23/12 12 Yes Yes 14 36 Yes
13/M 81 38/12 20 Yes No 20 20 Yes
Abbreviations: APACHE II Acute Physiology And Chronic Health Evaluation II score at ICU admission, CAM-ICU Confusion Assessment Method in the Intensive Care
Unit, ICU Intensive care unit, n.a. Not applicable (analgosedation), SAE Sepsis-associated encephalopathy, SOFA Sepsis-related Organ Failure Assessment
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Table 3 Results of magnetic resonance imaging and electroencephalography
Patient Days from sepsis onset to MRI MRI white matter hyperintensities MRI ischemic lesions Days to EEG EEG abnormalities
1 27 Diffuse No 4 Theta activity
2 8 Diffuse Yes 1 Theta activity
3 7 None No 4 Theta activity
4 7 None No 3 Theta activity
5 9 Patchy/confluent No 0 Theta activity
6 9 Punctiform Yes 2 Delta activity
7 12 None No 4 Delta activity
8 4 Punctiform No 1 Delta activity
9 10 Patchy/confluent No 2 Delta activity
10 10 Diffuse No 2 Theta activity
11 17 None No 4 Theta activity
12 4 Punctiform No 1 Delta activity
13 5 Patchy/confluent Yes 2 Delta activity
EEG Electroencephalography, MRI Magnetic resonance imaging
Fig. 3 Brain magnetic resonance imaging of three patients during septic shock. The images are fluid-attenuated inversion recovery (FLAIR; a, c, and e)
and echo planar imaging diffusion-weighted imaging (DWI; b, d, and f) scans. a and b An 81-year-old male patient with urosepsis. a Axial FLAIR image
obtained on day 5 after the onset of septic shock shows punctiform and confluent white matter hyperintensities (WMH) in both paraventricular and
paramedian regions (grade 2 leukoencephalopathy). b DWI study shows subacute ischemic lesion in the left occipital paramedian region. c and d An
80-year-old female patient with urosepsis. (c) Axial FLAIR image obtained 9 days after the onset of septic shock shows confluent WMH in the left
periventricular region (grade 2 leukoencephalopathy). d DWI study shows bilateral ischemic lesions in the frontal region. e and f An 80-year-old female
patient with urosepsis. e Axial FLAIR performed 8 days after onset of septic shock revealing a single punctiform WMH in the left periventricular region
(grade 1 leukoencephalopathy). f DWI study shows punctiform ischemic lesions in the left occipital and parietal (inset) regions
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(n = 3), or diffuse (n = 3). The second pattern of WMH
was ischemic (n = 3) (Table 3, Fig. 3).
Discussion
The present translational study was performed to dem-
onstrate evidence of axonal injury in the septic brains of
animals and humans. Previous animal studies offer some
evidence for different pathologic mechanisms of septic
brain injury and behavioral changes [8–10, 12, 14, 39].
The histologic findings in the rat brains in the present
study suggest two major mechanisms of injury. By βAPP
staining, both diffuse axonal injury (DAI) and ischemic
lesions were visible in the septic rat brain but not in
sham-treated animals. Furthermore, βAPP staining
showed abnormal axons along the white matter tracts.
Pockets of inflammatory and ischemic lesions were de-
tected by H&E staining. Further evidence for brain le-
sions in terms of disorientation of white matter was seen
in β-tubulin staining of the septic animals but not the
sham-treated group.
Our postmortem histologic samples of human septic
brains showed results comparable to those derived from
animal studies. Both βAPP staining and immunohistol-
ogy for nonphosphorylated NfH monoclonal antibodies
(SMI32) indicated DAI. Amyloid plaques were found
only in human septic brains with βAPP staining, but
they were completely absent in the rat histology. In con-
trast, Schwalm et al. reported increased Aβ levels in ex-
perimental sepsis [14]. Sharshar et al. noted various
cerebral pathologies in patients who died as a result of
sepsis, including ischemic lesions and neuronal apop-
tosis [40, 41]. The results of our present study are there-
fore in line with these previous reports, although our
neuropathologic findings point to ischemia and DAI as
the main mechanisms of brain injury. Owing to a longer
interval from death to brain sampling in the patients,
the histologic detection of DAI could represent a neuro-
pathologic artifact. The importance of amyloid plaques
within the human but not the animal brain histology is
uncertain. These plaques could have predated the fatal
sepsis episodes. Currently, on one hand, it can only be
speculated that patients with amyloid plaques have a
higher risk of developing SAE. Amyloid plaques, on the
other hand, could be the result of a severe inflammatory
stimulus to the brain, resulting in neurodegeneration
and SAE, as shown before [14].
A limitation of both the human postmortem and ex-
perimental histologic studies was that investigations
were restricted to brain tissue. There was no assessment
of spinal cord tissue. The longest and, for DAI, most vul-
nerable axons travel through the spinal cord white mat-
ter tracts. We have previously demonstrated spinal cord
involvement in a postmortem study of patients who died
following West Nile virus infection [42]. Therefore, this
study falls short of a conclusive demonstration of the
anatomical distribution of diffuse white matter tract
axonal injury in sepsis. Another limitation in this con-
text is the lack of quantitative neuropathology. A poten-
tial future study may need to consider to correlate
histological neuron/axon count with tissue body fluid
levels [43].
It would clearly be useful to diagnose brain injury in pa-
tients with sepsis as early as possible for neurologic prog-
nostication [21, 44]. Compared with improvements within
neuropathology to detect DAI, routinely available in vivo
diagnostics still lack the precision to accurately diagnose
brain injury [45, 46]. In all clinically assessable patients with
sepsis in the present study, clinical signs of SAE were
present at the onset of sepsis, and this is consistent with
pathologic EEG findings, as reported before [37, 47]. Never-
theless, the value of results derived from EEG examinations
in the ICU setting is still under debate [19]. There was no
statistically significant correlation between EEG and MRI
results. We found that delirium screening systems such as
CAM-ICU could not reliably detect SAE at all study points,
owing to a high proportion of patients requiring sedation
and mechanical ventilation. A clinical bedside diagnosis of
SAE is not routinely feasible and is a well-recognized short-
coming of clinical assessment in ICU patients [19, 20, 48].
Specific biomarkers for neuroaxonal injury could be helpful
in diagnosing DAI or SAE in vivo [49]. Previous clinical
studies have been focused on neuron-specific enolase and
S100B to diagnose brain injury in sepsis, with heteroge-
neous results [23]. Elevated Nf levels as markers of axonal
injury were detected in various neurological conditions and
may be of future use in SAE [49, 50].
In line with previous reports [21, 22], cerebral MRI
did indicate brain injury in the majority of our patients.
MRI findings suggested different extents of acute brain
injury. In addition to WMH, acute or subacute ischemic
lesions were detected in some of our patients. Compared
with diffusion tensor imaging (DTI), conventional MRI
techniques underestimate the extent of DAI [51, 52]. We
can only hypothesize about more extensive axonal injury
in our patients because they were examined only by
MRI. Consistent with our postmortem neuropathological
findings, the in vivo MRI results confirmed axonal and
ischemic brain injury in our patients. We assume the in-
flammatory pockets in the postmortem histology to be
correlates to the punctiform WMH seen on MRI scans.
Although patients with any preexisting central nervous
system pathology were not included in our study, we
cannot exclude that some patients might have had sub-
clinical brain injury before study inclusion that was
interpreted as newly detected WMH. However, the is-
chemic lesions seen on MRI scans were undoubtedly
newly present and provide striking evidence for ischemic
brain injury during sepsis.
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Conclusions
Axonal and ischemic brain injuries were detected in sep-
tic rat and postmortem human brain neuropathology
and appear to be important mechanisms underlying
SAE. The MRI findings of ischemic lesions and WMH
were the best correlates to neuropathology. For in vivo
detection of axonal injury in SAE, Nf body fluid levels
should be analyzed longitudinally. DTI could be an op-
tion for detecting DAI in vivo more appropriately and
should be considered in further clinical studies.
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